NAPANEE, Ontario – VIVO Cannabis Inc. (TSX: VIVO), (OTCQX: VVCIF) (“VIVO” or the “Company”) immediately introduced that its subsidiary, Beacon Medical Australia Pty. Ltd. (“Beacon Medical Australia”), entered into an settlement with MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”), a subsidiary of MediPharm Labs Corp. (TSX: LABS) (“MediPharm Labs”), whereby MediPharm Labs Australia will provide pharmaceutical-quality (GMP licensed), formulated hashish oil merchandise to Beacon Medical Australia to promote into the Australian market.
“VIVO’s international efforts remain focused on the emerging Australian and German markets and we continue to seek out partnerships with organizations that have proven track records,” mentioned Barry Fishman, CEO of VIVO. “For this reason, we are thrilled to be working with MediPharm Labs to leverage their GMP production capabilities to accelerate our Australian market presence. We are confident this will allow us to continue to provide our Australian patients with the medical-grade products they have come to expect from the Beacon Medical brand.”
“Just weeks after MediPharm Labs Australia was granted GMP Certification, we’re pleased to announce this agreement that underscores the burgeoning demand for our specialized skills and rapid success in converting our opportunity pipeline into tangible, revenue-generating business,” mentioned Warren Everitt, CEO, Asia Pacific, MediPharm Labs. “We are excited to be working with VIVO to bring high quality products to medical consumers across Australia and other emerging markets.”
MediPharm Labs is a worldwide chief in specialised, research-driven pharmaceutical-quality hashish extraction, distillation and by-product merchandise. Under the settlement with Beacon Medical Australia, which has an preliminary one-year time period topic to renewal, MediPharm Labs Australia will provide a full vary of GMP-certified, formulated CBD and THC hashish oil merchandise to Beacon Medical Australia for additional distribution below its personal branding.
About VIVO Cannabis
VIVO Cannabis is acknowledged for trusted, premium hashish services and products. It holds manufacturing and gross sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation amenities with proprietary plant-growing know-how in Hope, British Columbia and Napanee, Ontario. VIVO has a group of premium manufacturers, every focusing on totally different buyer segments, together with Canna Farms, Beacon Medical, Fireside, Fireside-X, Lumina and Canadian Bud Collection. The Company is increasing its manufacturing capabilities and distribution community. Harvest Medicine, VIVO’s patient-centric, scalable community of medical hashish clinics, has serviced over 100,000 affected person visits. VIVO is pursuing a number of partnership and product growth alternatives and is focusing its worldwide efforts on Germany and Australia. The Company has a wholesome stability sheet and is well-positioned to speed up its path to profitability. For extra info go to: www.vivocannabis.com